M&G Investment Management LTD Organon & Co. Transaction History

M&G Investment Management LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$21.42 - $32.08 $354,929 - $531,565	16,570 Added 7.08%	250,612 $5.89 Million
Q4 2022 Jan 27, 2023	SELL	$23.31 - $28.61 $1.25 Million - $1.53 Million	-53,542 Reduced 18.62%	234,042 $0
Q3 2022 Nov 01, 2022	BUY	$23.4 - $34.25 $1.35 Million - $1.97 Million	57,548 Added 25.02%	287,584 $6.61 Million
Q2 2022 Aug 25, 2022	SELL	$31.66 - $38.9 $453,181 - $556,814	-14,314 Reduced 5.86%	230,036 $7.82 Million
Q1 2022 May 13, 2022	SELL	$30.45 - $39.36 $1.94 Million - $2.5 Million	-63,601 Reduced 20.65%	244,350 $8.55 Million
Q4 2021 Jan 18, 2022	BUY	$28.67 - $37.13 $222,708 - $288,425	7,768 Added 2.59%	307,951 $9.24 Million
Q3 2021 Nov 09, 2021	BUY	$28.63 - $35.64 $1.53 Million - $1.91 Million	53,612 Added 21.74%	300,183 $9.84 Million
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $7.01 Million - $9.37 Million	246,571 New	246,571 $7.4 Million

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on M&G Investment Management LTD with notifications on news.